Register
Login:
Share:
Email Facebook Twitter


Exclusive: Hayden Locke, CEO Emmerson plc, a low cost high margin potash investment
Richard Slape, Oil consultant - Avoiding Losers and Picking Winners, his personal strategy


Advanced Medical Solutions Broker Ratings



Broker Ratings for Advanced Medical Solutions (AMS)


Share Price: 313.50Bid: 312.50Ask: 314.00Change: 0.00 (0.00%)No Movement on Advanced Med.
Spread: 1.50Spread as %: 0.48%Open: 320.00High: 0.00Low: 0.00Yesterday’s Close: 313.50


Broker Recommendations for Advanced Medical Solutions (AMS)
Date Broker Rating Old Target New Target Change
13-Mar-19NumisAdd-340.00Reiteration
14-Mar-18NumisHold275.00275.00Reiteration
13-Sep-17InvestecHold-314.00Reiteration
13-Sep-17N+1 SingerSell--Downgrade
14-Mar-17Numis SecuritiesAdd-275.00Downgrade
14-Mar-17N+1 SingerHold-177.00Reiteration
06-Mar-17Numis SecuritiesBuy-260.00Upgrade
14-Sep-16NumisHold-235.00Reiteration
16-Mar-16InvestecAdd-195.00Reiteration
30-Jun-15finnCapHold-127.00Reiteration
25-Jun-15Canaccord GenuitySell122.00122.00Reiteration
25-Jun-15InvestecBuy-152.00Reiteration
04-Mar-15Panmure GordonHold102.00126.00Reiteration
04-Mar-15Numis SecuritiesHold122.00137.00Reiteration
04-Mar-15Canaccord GenuitySell-112.00Reiteration


Registered members see more Advanced Medical Solutions broker ratings!
Sign up here for your free account.




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.